IR-Med Inc. (IRME)

USD 0.83

(0.0%)

Market Cap (In USD)

58.93 Million

Revenue (In USD)

-

Net Income (In USD)

-4.9 Million

Avg. Volume

296.00

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.33999-1.65
PE
-
EPS
-
Beta Value
1.44
ISIN
US46265R1032
CUSIP
-
CIK
1839133
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Mr. Ran Ziskind
Employee Count
-
Website
https://www.ir-medical.com
Ipo Date
2021-01-26
Details
IR-Med Inc., a development stage medical device company, focuses on the development of infra-red light spectroscopy combined with artificial intelligence technology platform to address diagnostic or medical needs. It is developing PressureSafe, a handheld optical monitoring device to support early detection of pressure injuries to the skin and underlying tissue primarily caused by prolonged pressure associated with bed confinement; and Nobiotics, an otoscope to support physicians with an immediate indication as to whether mid-ear infection (Otitis Media), a common malady in children. The company is headquartered in Rosh Pina, Israel.